SCHEMBL10012031

SCHEMBL10012031

CCOC(=O)CC(O[Si](CC)(CC)CC)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
ALOX15 P16050 3/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CHRM1 P11229 1/20 0.41
ADORA1 P30542 1/20 0.41
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
TRPA1 O75762 1/20 0.38
CYP2D6 P10635 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.33
PTGS2 P35354 1/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10012109 0.83 ALDH1A1 (0.42) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL10011330 0.78 TSHR (0.41) CYP3A4TSHRTDP1
SCHEMBL10012490 0.78 L3MBTL1 (0.34) L3MBTL1
SCHEMBL12497459 0.76 ALOX15 (0.34) ALDH1A1ALOX15HSD17B10MGAMGAA
SCHEMBL4984393 0.76 MGAM (0.46) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL1245715 0.76 ALDH1A1 (0.50) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL22040635 0.76 MGAM (0.46) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL13136942 0.75 ALDH1A1 (0.53) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL10979567 0.73 ALDH1A1 (0.44) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1
SCHEMBL10012669 0.73 ALDH1A1 (0.46) ALDH1A1ALOX15CYP3A4HSD17B10CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 ALDH1A1 2965/4885ALOX15 1722/4885CYP3A4 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.